Summary:
This study is to investigate the long-term safety of Fezolinetant in women suffering from vasomotor symptoms (hot flashes) associated with menopause.
Qualified Participants Must:
• Women between 40-65 years of age
•
Must not have had a hysterectomy (partial or full)
•
Must not be currently taking any hormonal medications
Qualified Participants May Receive:
- Physical performed by a board certified physician
- Compensation for time and travel
- Study related procedures such as blood work and EKG